Ausgewählte Publikationen

Nephropathologie

Leiterin:
Prof. Dr. med. Kerstin Amann

Ausgewählte Publikationen

  • Zebrowski DC, Vergarajauregui S, Wu CC, Piatkowski T, Becker R, Leone M, Hirth S, Ricciardi F, Falk N, Giessl A, Just S, Braun T, Weidinger G, Engel FB. Developmental alterations in centrosome integrity contribute to the post-mitotic state of mammalian cardiomyocytes. Elife. 2015; 4. doi: 10.7554/eLife.05563
  • Novoyatleva T, Sajjad A, Pogoryelov D, Patra C, Schermuly RT, Engel FB. FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14. FASEB J. 2014; 28(6):2492-503. doi: 10.1096/fj.13-243576
  • Patra C, van Amerongen MJ, Ghosh S, Ricciardi F, Sajjad A, Novoyatleva T, Mogha A, Monk KR, Mühlfeld C, Engel FB. Organ-specific function of adhesion G protein-coupled receptor GPR126 is domain-dependent. Proc Natl Acad Sci U S A. 2013; 110(42):16898-903. doi: 10.1073/pnas.1304837110
  • Novoyatleva T, Schymura Y, Janssen W, Strobl F, Swiercz JM, Patra C, Posern G, Wietelmann A, Zheng TS, Schermuly RT, Engel FB. Deletion of FN14 receptor protects from right heart fibrosis and dysfunction. Basic Res Cardiol. 2013; 108(2):325. doi: 10.1007/s00395-012-0325-x
  • Patra C, Ricciardi F, Engel FB. The functional properties of nephronectin: An adhesion molecule for cardiac tissue engineering. Biomaterials. 2012; 33(17):4327-35. doi: 10.1016/j.biomaterials.2012.03.021
  • Patra C, Talukdar S, Novoyatleva T, Velagala SR, Mühlfeld C, Kundu B, Kundu SC, Engel FB. Silk protein fibroin from Antheraea mylitta for cardiac tissue engineering. Biomaterials. 2012; 33(9):2673-80. doi: 10.1016/j.biomaterials.2011.12.036
  • Patra C, Diehl F, Ferrazzi F, van Amerongen MJ, Novoyatleva T, Schaefer L, Mühlfeld C, Jungblut B, Engel FB. Nephronectin regulates via BMP4-HAS2 signaling the differentiation of the atrio-ventricular canal in zebrafish. Development. 2011; 138(20):4499-509. doi: 10.1242/dev.067454
  • van Amerongen MJ, Diehl F, Novoyatleva T, Patra C, Engel FB. E2F4 is required for cardiomyocyte proliferation. Cardiovasc Res. 2010; 86(1):92-102. doi: 10.1093/cvr/cvp383
  • Novoyatleva T, Diehl F, van Amerongen MJ, Patra C, Ferrazzi F, Bellazzi R, Engel FB. TWEAK is a positive regulator of cardiomyocyte proliferation. Cardiovasc Res. 2010; 85(4):681-90. doi: 10.1093/cvr/cvp360
  • Engel FB, Hsieh PCH, Lee RT, Keating MT. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring and rescues function after myocardial infarction. Proc Natl Acad Sci U S A. 2006; 103(42):15546-51 (co-corresponding author)
  • Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT. p38 MAP Kinase Inhibition Enables Proliferation of Adult Mammalian Cardiomyocytes. Genes Dev. 2005; 19(10):1175-87
 

Leitung:

Prof. Dr. rer. nat. Felix Engel